Close Menu

NEW YORK (GenomeWeb) – Investment bank Piper Jaffray today initiated coverage of Danaher with a Neutral rating on the firm's stock and Agilent Technologies with an Overweight rating.

In an investment note, analyst William Quirk put a $148 target on Danaher's stock, saying the Washington, DC-based conglomerate's "underlying businesses are well positioned with the Danaher Business System and synergies sources of further growth and improvement."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.

By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.

NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.

In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.